Angelique E. M. Mayen

783 citations
13 papers · 656 indexed · h-index 10

Angelique E. M. Mayen

13 papers receiving 644 citations

Peers

Angelique E. M. Mayen
Comparison fields: 5 of 65
  • Hematology 205
  • Genetics 139
  • Immunology 163
  • Pharmacology 75
  • Oncology 113
Replace Yi-Shiuan Tzeng with:
Yi-Shiuan Tzeng Taiwan
R Wilmotte France
Drorit Luria Israel
Tatyana Grinenko Germany
Kinori Kosaka Japan
Saleem Dar United States
Harry Holzmüller Germany
Mark Malin Australia
Emmalee R. Adelman United States
Sharon Lin United States
Angelique E. M. Mayen relative to Yi-Shiuan Tzeng Taiwan Yi-Shiuan Tzeng's profile →
Citations per field
00.5×1.5×2.0×
Yi-Shiuan Tzeng · 1×
Citations per year

Countries citing papers authored by Angelique E. M. Mayen

Since Specialization
Citations

This map shows the geographic impact of Angelique E. M. Mayen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelique E. M. Mayen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelique E. M. Mayen more than expected).

Fields of papers citing papers by Angelique E. M. Mayen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelique E. M. Mayen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelique E. M. Mayen. The network helps show where Angelique E. M. Mayen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Angelique E. M. Mayen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Angelique E. M. Mayen Line = papers co-authored together Angelique E. M. Mayen links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1 200030
2 200078
3 200033
4 1999111
5 1998140
6 199810
7 199729
8 199789
9 19976
10 199627
11 19949
12 19947
13 199387

About Angelique E. M. Mayen

Angelique E. M. Mayen is a scholar working on Hematology, Genetics, Immunology, Nephrology and Pharmacology, having authored 13 papers that have together received 656 indexed citations. Recurring topics across this work include Connexins and lens biology (4 papers), Heat shock proteins research (3 papers), Mesenchymal stem cell research (2 papers), Erythrocyte Function and Pathophysiology (2 papers), Cannabis and Cannabinoid Research (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Cancer Cells and Metastasis (2 papers) and Research on Leishmaniasis Studies (1 paper). The work is most often cited by research in Hematology (205 citations), Genetics (139 citations), Immunology (163 citations), Pharmacology (75 citations) and Oncology (113 citations). Angelique E. M. Mayen has collaborated with scholars based in Netherlands, United Kingdom and Australia. Frequent co-authors include Rob E. Ploemacher, Dimitri Breems, Ellen A.W. Blokland, Ivo P. Touw, Mirjam H. A. Hermans, José A. Cancelas, Alister C. Ward, Elwin Rombouts, Antoon F.M. Moorman and Petra W. Oosthoek. Their work appears in journals such as Blood, Infection and Immunity, Circulation Research, Nephrology Dialysis Transplantation and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026